Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 297.47 million compared to CNY 271.06 million a year ago. Revenue was CNY 297.47 million compared to CNY 271.06 million a year ago.

Net loss was CNY 71.49 million compared to CNY 20.53 million a year ago. Basic loss per share from continuing operations was CNY 0.4495 compared to CNY 0.1404 a year ago. Diluted loss per share from continuing operations was CNY 0.4495 compared to CNY 0.1404 a year ago.